Our board

The BIA’s Board is drawn from a wide range of member companies. The Board currently comprises 11 Members, each of whom has been elected for a three-year term, after which they are invited to put themselves forward for re-election.

Board Members

Chair of the Board

Dr Dan Mahony

Dr Dan Mahony

Evotec

Corporate Members

Lisa Anson

Lisa Anson

CEO , Redx Pharma

David Atkins

David Atkins

Chief Executive Officer , Congenica

Charlotte Casebourne

Charlotte Casebourne

CEO , Theolytics

Olivia Cavlan

Olivia Cavlan

Head of Business & Operations , Alchemab

Nicole Farmer

Nicole Farmer

General Manager , Sanofi Genzyme

Oliver Hardick

Oliver Hardick

Director , Cytiva

Professor Jackie Hunter

Professor Jackie Hunter

Chief Executive Officer, Benevolent Bio and Director of BenevolentAI , BenevolentAI

Dr Ruth McKernan

Dr Ruth McKernan

Chair , Astronautx

Deborah O'Neil

Deborah O'Neil

Chief Executive Officer , NovaBiotics

Dr Mike Romanos

Dr Mike Romanos

CEO , Microbiotica

Nerida Scott

Nerida Scott

Head of Johnson & Johnson Innovation, EMEA , Johnson & Johnson Innovation

Sunil Shah

Sunil Shah

CEO , Opal Oncology

Dr Avi Spier

Dr Avi Spier

Executive Director, Head of Search & Evaluation/Region UK , Novartis Institute for Biomedical Research

Clare Terlouw

Clare Terlouw

Head of LifeArc Ventures , LifeArc

Dr Peter Finan

Dr Peter Finan

Partner , Epidarex Capital

 

 Steve Bates FMed Sci, OBE

Steve Bates FMed Sci, OBE

CEO Bio Industry Association , BIA

 

Nick Gardiner

Nick Gardiner

Chief Operating Officer , BIA